Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Liabilities (2016 - 2025)

Sanara MedTech's Total Liabilities history spans 15 years, with the latest figure at $67.0 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 36.26% year-over-year to $67.0 million; the TTM value through Dec 2025 reached $67.0 million, up 36.26%, while the annual FY2025 figure was $67.0 million, 36.26% up from the prior year.
  • Total Liabilities reached $67.0 million in Q4 2025 per SMTI's latest filing, up from $64.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $67.0 million in Q4 2025 to a low of $3.5 million in Q1 2021.
  • Average Total Liabilities over 5 years is $29.0 million, with a median of $23.6 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: decreased 7.81% in 2021, then surged 273.54% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $6.2 million in 2021, then surged by 209.32% to $19.3 million in 2022, then skyrocketed by 51.61% to $29.3 million in 2023, then skyrocketed by 67.95% to $49.2 million in 2024, then skyrocketed by 36.26% to $67.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Total Liabilities are $67.0 million (Q4 2025), $64.9 million (Q3 2025), and $63.4 million (Q2 2025).